Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial

Publication | Closed Access

DOI

Citations

References

2019

Year

Christian Anholm, Preman Kumarathurai, Lene Rørholm Pedersen, Amirsalar Samkani, Rosemary L. Walzem, Olav Wendelboe Nielsen, Ole Peter Kristiansen, Mogens Fenger, Sten Madsbad, Ahmad Sajadieh,

Atherosclerosis

ObesityMetabolic SyndromeC-reactive Protein LevelCardiovascular DiseaseMedicineDiabetesType 2HyperlipidemiaRandomized TrialPharmacologyAtherosclerosisDyslipidemia